Clinical Trials Directory

Trials / Completed

CompletedNCT02769910

Effects of High-concentration Topical Capsaicin on Histaminergic and Non-histaminergic Itch

The Role of Pre-established Skin Inflammation on the Susceptibility to Histamine and Cowhage-induced Itch in Healthy Humans

Status
Completed
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
16 (actual)
Sponsor
Hjalte Holm Andersen · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

The purpose of this project is to investigate the effect of capsaicin-induced neurogenic inflammation with three different intensities on itch subsequently induced by histamine and cowhage. The hypothesis is that capsaicin-induced pre-established neurogenic inflammation significantly increases susceptibility to itch provocations with cowhage and histamine.

Conditions

Interventions

TypeNameDescription
DRUGCapsaicin 24 HoursDermal patches for transdermal application of Capsaicin, applied for 24 hours
DRUGCapsaicin 1 HourDermal patches for transdermal application of Capsaicin, applied for 1 hour
OTHERQutenza Demo PatchDermal patches mimicking active Qutenza patches. Used as control in comparison of Capsaicin efficacy. Applied for 24 hours.

Timeline

Start date
2016-05-01
Primary completion
2016-07-01
Completion
2016-07-01
First posted
2016-05-12
Last updated
2016-11-22

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT02769910. Inclusion in this directory is not an endorsement.